758 related articles for article (PubMed ID: 18684926)
1. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
2. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
Favier B; Lemaoult J; Lesport E; Carosella ED
FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
Morel E; Bellón T
Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N
J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.
Ince MN; Harnisch B; Xu Z; Lee SK; Lange C; Moretta L; Lederman M; Lieberman J
Immunology; 2004 Aug; 112(4):531-42. PubMed ID: 15270723
[TBL] [Abstract][Full Text] [Related]
6. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells.
Tenca C; Merlo A; Merck E; Bates EE; Saverino D; Simone R; Zarcone D; Trinchieri G; Grossi CE; Ciccone E
J Immunol; 2005 Jun; 174(11):6757-63. PubMed ID: 15905516
[TBL] [Abstract][Full Text] [Related]
7. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
8. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Kanto T; Tatsumi T; Groh V; Spies T; Miyagi T; Suzuki T; Sasaki Y; Hayashi N
J Immunol; 2003 Feb; 170(3):1249-56. PubMed ID: 12538683
[TBL] [Abstract][Full Text] [Related]
9. Human M2 Macrophages Limit NK Cell Effector Functions through Secretion of TGF-β and Engagement of CD85j.
Nuñez SY; Ziblat A; Secchiari F; Torres NI; Sierra JM; Raffo Iraolagoitia XL; Araya RE; Domaica CI; Fuertes MB; Zwirner NW
J Immunol; 2018 Feb; 200(3):1008-1015. PubMed ID: 29282306
[TBL] [Abstract][Full Text] [Related]
10. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
11. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
12. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.
Gonen-Gross T; Achdout H; Arnon TI; Gazit R; Stern N; Horejsí V; Goldman-Wohl D; Yagel S; Mandelboim O
J Immunol; 2005 Oct; 175(8):4866-74. PubMed ID: 16210588
[TBL] [Abstract][Full Text] [Related]
13. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
[TBL] [Abstract][Full Text] [Related]
16. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells.
Scott-Algara D; Arnold V; Didier C; Kattan T; Pirozzi G; Barré-Sinoussi F; Pancino G
PLoS One; 2008 Apr; 3(4):e1975. PubMed ID: 18398485
[TBL] [Abstract][Full Text] [Related]
17. HLA-G modulates immune responses by diverse receptor interactions.
Hofmeister V; Weiss EH
Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
[TBL] [Abstract][Full Text] [Related]
19. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
20. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
